Sort
64,565 grants matching “drug discovery”
Project 2: Use of 2D cultures and 3D organoids to identify candidate antiviral compounds; to use genetic approaches to identify host genes that promote or protect against flavivirus infection
$1,107,390Lee Gehrke · Massachusetts Institute Of Technology · U19 · FY2019 · AI
The Hepato/Renal Fibrocystic Disease Core Center
$1,106,739Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2016 · DK
Metal-Catalyzed Methods for Organic Synthesis
$1,106,564Stephen L Buchwald · Massachusetts Institute Of Technology · R35 · FY2021 · GM
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION
$1,106,441Rockefeller University · R01 · FY2002 · DA
UWCCC National Cooperative Drug Discovery Group for Cancer
$1,106,244University Of Wisconsin Madison · U19 · FY2005 · CA
RESBIO - the Technology Resource for Polymeric Biomaterials
$1,106,190Joachim B. Kohn · Rutgers, The State Univ Of N.J. · P41 · FY2012 · EB
Lead Identification to Clinical Candidate Selection: Drugs for Chagas Disease
$1,106,134James H. McKerrow · University Of California, San Diego · R01 · FY2014 · AI
Optimization of efflux avoidance and inhibition for antibiotic development
$1,106,111Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2021 · AI
Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses
$1,106,083Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2014 · AI
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity
$1,106,000Robin Knight · University Of California, San Diego · DP1 · FY2023 · AT
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity
$1,106,000Robin Knight · University Of California, San Diego · DP1 · FY2022 · AT
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity
$1,106,000Robin Knight · University Of California, San Diego · DP1 · FY2021 · AT
Targeted Discovery of Marine-derived Anticancer Leads
$1,105,895Phil Crews · University Of California Santa Cruz · U19 · FY2007 · CA
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity
$1,105,720D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH2 · FY2012 · TR
Xenobiotic-Metabolizing Enzymes
$1,105,643Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Metal-Catalyzed Methods for Organic Synthesis
$1,105,287Stephen L Buchwald · Massachusetts Institute Of Technology · R35 · FY2019 · GM
National Academy of Sciences' Board on Chemical Sciences and Technology (BCST) and the Chemical Sciences Roundtable (CSR)
$1,105,000Charles D Ferguson · National Academy Of Sciences · · FY2024 · MPS
Metal-Catalyzed Methods for Organic Synthesis
$1,104,677Stephen L Buchwald · Massachusetts Institute Of Technology · R35 · FY2018 · GM
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,104,636Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2022 · CA
RESBIO - the Technology Resource for Polymeric Biomaterials
$1,104,548Joachim B. Kohn · Rutgers, The State Univ Of N.J. · P41 · FY2011 · EB
Tumor Plasticity
$1,104,176Dario C. Altieri · Wistar Institute · R35 · FY2019 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,103,955Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
DNA Topoisomerases as Target of Action of Anticancer Drugs
$1,103,955Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Center for Interventional Oncology
$1,103,817Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$1,103,435Richard K. Plemper · Georgia State University · R01 · FY2019 · AI